phosphatidyl glycerol/neoplasms

FIELD OF THE INVENTION The present invention provides novel lipophilic disaccharide-tripeptide compounds having improved immunological efficacy, and a liposome encapsulated composition comprising said compounds. BACKGROUND OF THE INVENTION Intact microbial agents are known to have immunological

FIELD OF THE INVENTION The present invention provides a novel lipophilic disaccharide-tripeptide compound having improved anti-tumor efficacy, and a liposome encapsulated composition comprising said compound. BACKGROUND OF THE INVENTION Intact microbial agents ar known to have antitumor effects in

BACKGROUND Interleukin-12 is an immunostimulating cytokine that can stimulate both natural killer cells (nk) and t-cells. Because of these properties, IL-12 has been evaluated in animal models for anti tumor activity. These various animal models have shown partial and complete tumor regression,